Skip Navigation LinksHome > March 2014 - Volume 36 - Issue 2 > Congenital Neuroblastoma in a Neonate With Isotretinoin Embr...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318290c39e
Online Articles: Clinical and Laboratory Observations

Congenital Neuroblastoma in a Neonate With Isotretinoin Embryopathy

Aguilar, Shiley MSN, RN, FNP-C; Louis, Chrystal MD, MPH; Hicks, John MD, DDS, PhD; Zage, Peter MD, PhD; Russell, Heidi MD

Collapse Box


We describe a neonate with isotretinoin embryopathy and an incidental finding of congenital neuroblastoma. Diffuse liver metastases led to the decision to provide oncologic therapy followed by tumor resection. Despite the possible need for chronic care related to the comorbidities of the isotretinoin embryopathy and oncologic management, the patient remains disease-free. Because of the uncertain etiology of neuroblastoma, it remains unclear whether exposure to isotretinoin during embryogenesis and fetal development had an oncogenic effect on this patient.

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.